Aveek Mitra of Aveksat Financial Advisory has been spreading bets defensively post-election, keeping minimal cash. Focusing on chemicals, IT, and pharma, he emphasizes risk management over returns. Highlighting investments in mid-smallcap, consolidation phases, and API, Mitra addresses rising investor expectations and remains adaptable, leveraging a client base built without promotion.
On a wait and hold till April 2 as well as what happens over next 3-4 months: Seth R Freeman
Seth R Freeman of GlassRatner Advisory highlights the market’s uncertainty ahead of the April 2 tariff deadline and the potential impact on business planning. He
March 21, 2025